Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Atadja

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Cancer Letters|April 7, 2009
Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challengesPeter Atadja
Cancer Biology & Therapy|December 19, 2006
Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylationQun Zhou, Peter Atadja, Nancy E Davidson
The Journal of Biological Chemistry|April 12, 2002
Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase familyLin Gao, Maria A Cueto, Fred Asselbergs, et al.
Molecular Cancer Therapeutics|September 19, 2007
Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor-dependent human lung cancer cellsArthur Edwards, Jiannong Li, Peter Atadja, et al.
Novartis Foundation Symposium|May 7, 2002
Gene expression profiling of epothilone A-resistant cellsPeter Atadja, Yan Yan-Neale, Harry Towbin, et al.
Novartis Foundation Symposium|June 3, 2004
Molecular and cellular basis for the anti-proliferative effects of the HDAC inhibitor LAQ824Peter Atadja, Meier Hsu, Paul Kwon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2009
A histone deacetylase inhibitor LBH589 downregulates XIAP in mesothelioma cell lines which is likely responsible for increased apoptosis with TRAILJames Symanowski, Nicholas Vogelzang, Leigh Zawel, et al.
Molecular Cancer Research : MCR|May 29, 2008
Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cellsQun Zhou, Agoston T Agoston, Peter Atadja, et al.
Oncotarget|December 13, 2012
Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancerSreedhar Venkannagari, Warren Fiskus, Karissa Peth, et al.
Cancer Research|June 19, 2008
Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasionYonghua Yang, Rehka Rao, Jie Shen, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Cancer Letters|April 7, 2009
Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challengesPeter Atadja
Cancer Biology & Therapy|December 19, 2006
Histone deacetylase inhibitor LBH589 reactivates silenced estrogen receptor alpha (ER) gene expression without loss of DNA hypermethylationQun Zhou, Peter Atadja, Nancy E Davidson
The Journal of Biological Chemistry|April 12, 2002
Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase familyLin Gao, Maria A Cueto, Fred Asselbergs, et al.
Molecular Cancer Therapeutics|September 19, 2007
Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor-dependent human lung cancer cellsArthur Edwards, Jiannong Li, Peter Atadja, et al.
Novartis Foundation Symposium|May 7, 2002
Gene expression profiling of epothilone A-resistant cellsPeter Atadja, Yan Yan-Neale, Harry Towbin, et al.
Novartis Foundation Symposium|June 3, 2004
Molecular and cellular basis for the anti-proliferative effects of the HDAC inhibitor LAQ824Peter Atadja, Meier Hsu, Paul Kwon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2009
A histone deacetylase inhibitor LBH589 downregulates XIAP in mesothelioma cell lines which is likely responsible for increased apoptosis with TRAILJames Symanowski, Nicholas Vogelzang, Leigh Zawel, et al.
Molecular Cancer Research : MCR|May 29, 2008
Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cellsQun Zhou, Agoston T Agoston, Peter Atadja, et al.
Oncotarget|December 13, 2012
Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancerSreedhar Venkannagari, Warren Fiskus, Karissa Peth, et al.
Cancer Research|June 19, 2008
Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasionYonghua Yang, Rehka Rao, Jie Shen, et al.
Pageof 11